(Q45869616)

17 December 2017

title

Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression (English)

1 reference

17 December 2017

6

Alexander HR

1 reference

17 December 2017

David L Bartlett

7

object named as

Bartlett DL

1 reference

17 December 2017

Steven Libutti

5

object named as

Libutti SK

1 reference

17 December 2017

author name string

McCart JA

1

1 reference

17 December 2017

Puhlmann M

2

1 reference

17 December 2017

Lee J

3

1 reference

17 December 2017

Hu Y

4

1 reference

17 December 2017

publication date

1 July 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

14

1 reference

17 December 2017

page(s)

1217-1223

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301237

exact match

0 references

cites work

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Poxviruses as expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Serous cutaneous glands in Phyllomedusa hypochondrialis (Anura, Hylidae): secretory patterns during ontogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Structure of vaccinia virus late promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Structure of vaccinia virus early promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Virus-directed enzyme/prodrug therapy (VDEPT). Selectively engineering drug sensitivity into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

7 January 2021

Killing tumor cells with viruses--a question of specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

7 January 2021

Vaccinia virus for human gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

7 January 2021

Compact, synthetic, vaccinia virus early/late promoter for protein expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301237

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301237

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017